The COVID-19 pandemic has profound adverse effects on the population on dialysis.
Patients requiring dialysis are at an increased risk of SARS-CoV-2 infection and mortality …

The Coronavirus disease 2019 (COVID-19) pandemic poses a great threat to global public
health. The original wild-type strain of severe acute respiratory syndrome coronavirus 2 …

Bivalent SARS-CoV-2 Booster in Hemodialysis Patients In a group of patients undergoing
hemodialysis who had received four previous inoculations of SARS-CoV-2 vaccines, a fifth …

Venetoclax in Relapsed or Refractory Hairy-Cell Leukemia | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …

Background Patients with primary and secondary antibody deficiency are vulnerable to
COVID-19 and demonstrate diminished responses following two-dose SARS-CoV-2 vaccine …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immune responses and
infection outcomes were evaluated in 2,686 patients with varying immune-suppressive …

Results A total of 1121 in-center hemodialysis patients were included in the analysis; all
patients underwent weekly screening for SARS-CoV-2 infection via reverse transcriptase …

To the editor: Despite an initial satisfactory increase in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) antispike antibody (Ab) titer after completing a 3-dose regimen …

Despite progressive improvements in the management of patients with coronavirus disease
2019 (COVID-19), individuals with end-stage kidney disease (ESKD) are still at high risk of …

Hemodialysis patients are exposed to a markedly increased risk when infected with SARS-
CoV-2. To date, it is unclear if hemodialysis patients benefit from four vaccinations. A total of …